ATLAS_Antifungals

Primary Objective The ATLAS programme monitors changes in antibiotic susceptibility, bacterial resistance trends and emergence of new resistance mechanism for both marketed and in development antibiotics. In addition, provides genotypic information when tested. The SENTRY platform data allow for monitoring of antifungal susceptibility and resistance trending of key antifungals.

核心研究目标：ATLAS项目针对已上市及在研抗生素，持续监测其抗生素敏感性变化、细菌耐药趋势以及新型耐药机制的出现；此外，在开展相关检测时同步提供基因型信息。SENTRY平台的数据可用于监测关键抗真菌药物的抗真菌药物敏感性及耐药趋势。